AstraZeneca unveils positive results for danicopan in treating PNH
The ALPHA trial is designed to evaluate the efficacy and safety of danicopan as an add-on to C5…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
12 Jun 23
The ALPHA trial is designed to evaluate the efficacy and safety of danicopan as an add-on to C5…
12 Jun 23
The panel’s backing was based on the sBLA, which includes findings from Eisai’s global confirmatory Phase 3 Clarity…
12 Jun 23
The partnership intends to use in vivo electrophysiology solutions to drive neuroscience research and accelerate neurological drug discovery…
12 Jun 23
Survey of Unmet Needs in chronic myeloid leukemia (CML SUN) data signal need for amplified patient voice during…
12 Jun 23
The new platform is designed to enable the end-to-end analysis and clinical reporting of nanopore sequencing, empowering clinical…
09 Jun 23
The Japanese drugmaker will obtain an exclusive global license to develop, manufacture and commercialise KT430, for an undisclosed…
09 Jun 23
VEVYE, whose development name is CyclASol, is said to be the first and only cyclosporine solution indicated to…
09 Jun 23
Initially, the partnership will aim to synthesize and assess ADCs related to cryptophycins, an antitumor molecule, which will…
09 Jun 23
Under the partnership, Charles River will use its contract development and manufacturing organisation expertise in HQ plasmid DNA…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
09 Jun 23
Under the new agreement, Samsung Biologics will offer Pfizer access to supplementary capacity for large-scale manufacturing purposes